Allscripts Healthcare Solutions (MDRX)

Add to Watchlists Create an Alert
13.89 -0.07  -0.50%   NASDAQ May 23, 12:45PM BATS Real time Currency in USD

Allscripts Healthcare Solutions R&D Expense Quarterly:

49.99M for Dec. 31, 2012
View Full Chart

Allscripts Healthcare Solutions R&D Expense Quarterly Chart

    Allscripts Healthcare Solutions Historical R&D Expense Quarterly Data

    Pro Data Export
    Dates:  to
    Viewing 1 of 1   First  Previous First    Next  Last   Last

    There is no data for the selected date range.

    Data for this Date Range  
    Dec. 31, 2012 49.99M
    Sept. 30, 2012 37.80M
    June 30, 2012 38.24M
    March 31, 2012 36.12M
    Dec. 31, 2011 31.31M
    Sept. 30, 2011 26.03M
    June 30, 2011 24.76M
    March 31, 2011 22.00M
    Sept. 30, 2010 16.70M
       
    May 31, 2010 13.86M
    March 31, 2010 12.53M
    Feb. 28, 2010 12.65M
    Nov. 30, 2009 10.72M
    Aug. 31, 2009 11.98M
    May 31, 2009 10.63M
    Feb. 28, 2009 9.913M
    Nov. 30, 2008 10.93M

    About R&D Expense

    R&D expenses are a line item from many companies' income statements.

    R&D expense (short for research and development expense) is essentially the amount of money that a company spends to develop new products and services each year. For example, if a pharmaceutical firm hires research scientists to develop new drugs, the salaries of these researchers will generally be expensed in the R&D expense category.

    Like marketing expenses, but unlike capital expenditures, R&D expenses are subtracted from revenues every year directly. Therefore, accountants treat R&D spending as an expense rather than as an investment, though there is continuous debate over whether this is the correct classification.

    An investor looking at companies with large R&D expenditures should think hard about whether a single company's R&D spending is an expense (like buying rubber to produce tires) or whether it is an investment (like buying machinery to produce tires more efficiently). Determining the answer to that question can have a large impact on how the company is valued.
    Learn More

    Get data for

    MDRX R&D Expense Quarterly Benchmarks

    Companies
    AthenaHealth 11.94M
    Cerner Corporation 81.06M
    Quality Systems 7.786M

    MDRX R&D Expense Quarterly Rankings

    Overall 97th percentile
    202 of 8006
    Sector 89th percentile
    102 of 952 in Technology
    Industry 92nd percentile
    15 of 196 in Software - Application

    MDRX R&D Expense Quarterly Range, Past 5 Years

    Minimum 9.913M Feb 2009
    Maximum 49.99M Dec 2012
    Average 22.13M